Developing health, developing profits
April 30, 2009Research and Development, Sales and Marketing Pfizer, healthcare, working poor
Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Nexavar fails in melanoma study
April 30, 2009Research and Development Bayer, Cancer, Nexavar
Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
Recession hits Merck KGaA profits
April 29, 2009Sales and Marketing Merck Serono
Merck KGaA saw its profits fell through the floor for the first quarter this year due to a combination of …
Microdosing shows its mettle in cancer study
April 29, 2009Research and Development Microdosing
Newly-released data has added additional weight to the evidence for microdosing studies as a means to predict whether or not …
UK scientists to examine swine flu
April 29, 2009Research and Development h1n1
UK scientists will examine new samples of swine influenza as part of the global race to develop a vaccine against …
GSK pledges help in flu outbreak
April 28, 2009Research and Development GSK, h1n1
GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …
IDIS and Ogilvy to promote named patient programme
April 28, 2009Medical Communications, Sales and Marketing IDIS, Ogilvy
Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …
The changing face of Continuing Medical Education in Europe
April 28, 2009Medical Communications, Sales and Marketing Continuing medical education, Europe
There is currently no unified approach to delivering Continuing Medical Education (CME) in Europe, and the provision of CME is …
Patheon takeover stymied by regulators
April 28, 2009Manufacturing and Production Patheon
A hostile takeover bid for Canadian contract manufacturer Patheon by private equity firm JLL Partners has been blocked by the …
Pfizer taps UCL for stem cell expertise
April 28, 2009Research and Development Pfizer, UCL, ophthalmology, regenerative medicine
Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …
AZ’s Iressa to make comeback
April 28, 2009Research and Development, Sales and Marketing AZ, Iressa
AstraZeneca's Iressa is set to make a comeback after a European committee recommended its use for a sub-group of lung …
Questions and answers
April 27, 2009Medical Communications Pfizer, Q&A, communications
As a young child, I am reliably informed that "why" was my favourite word for an extended period. While that …
Mixed news for Biogen Idec on Tysabri
April 27, 2009Manufacturing and Production Biogen
Biogen Idec has won approval for a new high-titre manufacturing process for its multiple sclerosis product Tysabri (natalizumab) which should …
GSK and Pfizer joint venture more than a defensive move
April 27, 2009Research and Development, Sales and Marketing GSK, Pfizer
GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
Strong prospects for Novartis cancer drug, say analysts
April 24, 2009Research and Development, Sales and Marketing Afinitor, Novartis
The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …
GSK freezes prices in Germany as part of PR trail
April 24, 2009Sales and Marketing GSK, Germany
GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …
Merck Serono launches Kuvan in Europe
April 24, 2009Sales and Marketing Kuvan, Merck Serono, PKU
Kuvan, the first treatment for two rare neurological disorders, has been launched in the UK, France and Germany.Merck Serono’s drug …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
